Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Weight loss is a health intervention, not a magic solution for lifes complexities
Currently, Medicare plans typically dont cover Wegovy for weight loss, but they may cover it for cardiovascular risk reduction
Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause In ATTAIN-1, women in perimenopause taking Foundayo lost up to 30.4 lbs (14.4%) and those in post-menopause lost up to 28.2 lbs (14.1%) In ATTAIN-2, women taking Foundayo lost significant weight across all stages of menopause, despite the additional challenge of living with type 2 diabetes Across studies, women taking Foundayo saw meaningful reductions in their waist circumference, a measure associated with reduced abdominal fat and cardiometabolic risk Menopause is a major, yet often overlooked, driver of weight gain
10.1111/j.1742-1241.2009.02143.x 29 CharbonnelB.SchweizerA.DejagerS
